Krishna Institute of Medical Sciences inches up after its arm disinvests stake in favour of group of doctors
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Krishna Institute of Medical Sciences is currently trading at Rs. 1501.55, up by 0.75 points or 0.05% from its previous closing of Rs. 1500.80 on the BSE.
The scrip opened at Rs. 1509.35 and has touched a high and low of Rs. 1512.70 and Rs. 1500.00 respectively.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1669.10 on 15-Nov-2022 and a 52 week low of Rs. 1115.80 on 21-Jun-2022.
Last one week high and low of the scrip stood at Rs. 1543.00 and Rs. 1497.00 respectively. The current market cap of the company is Rs. 12007.37 crore.
The promoters holding in the company stood at 38.84%, while Institutions and Non-Institutions held 38.14% and 23.01% respectively.
Krishna Institute of Medical Sciences’ step-down subsidiary -- Suryateja Healthcare has disinvested its entire stake in favour of group of doctors (Karampudi Kamalakar, Nalamaru Vamsi, Suresh Kumar Thatipamula, Divya Puskur, and Omprakash Tumma (collectively to be called as Purchaser)) under an agreement to takeover company by transfer of shares.
Consequent upon the said dis-investment, Suryateja Healthcare ceased to be a step-down subsidiary of the Company. The agreement is effective from December 1, 2022. The Purchasers paid a total composite consideration of Rs 2.50 crore.
Krishna Institute of Medical Sciences offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.
